References
Key articles
Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Abstract
Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112-46.Full text Abstract
Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections and diseases - coccidioidomycosis/valley fever. May 2023 [internet publication].Full text
National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Coccidioidomycosis. 2021 [internet publication].Full text
Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text Abstract
Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Full text Abstract
Reference articles
1. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. 1990 Jul;3(3):247-68. Abstract
2. Galgiani JN. Coccidioidomycosis (Coccidioides species). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Elsevier, Inc; 2020:3190-200.
3. Sunenshine RH, Anderson S, Erhart L, et al. Public health surveillance for coccidioidomycosis in Arizona. Ann NY Acad Sci. 2007 Sep;1111:96-102. Abstract
4. Thompson GR 3rd, Le T, Chindamporn A, et al. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis. 2021 Dec;21(12):e364-74. Abstract
5. Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016 Sep 15;63(6):e112-46.Full text Abstract
6. Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis) statistics. Apr 2022 [internet publication].Full text
7. Mazi PB, Sahrmann JM, Olsen MA, et al. The geographic distribution of dimorphic mycoses in the United States for the modern era. Clin Infect Dis. 2023 Apr 3;76(7):1295-301. Abstract
8. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections and diseases - coccidioidomycosis/valley fever. May 2023 [internet publication].Full text
9. Laws RL, Jain S, Cooksey GS, et al. Coccidioidomycosis outbreak among inmate wildland firefighters: California, 2017. Am J Ind Med. 2021 Apr;64(4):266-73.Full text Abstract
10. Centers for Disease Control and Prevention. CDC surveillance summaries: surveillance for coccidioidomycosis, histoplasmosis, and blastomycosis - United States, 2019. Aug 2022 [internet publication].Full text
11. Ruddy BE, Mayer AP, Ko MG, et al. Coccidioidomycosis in African Americans. Mayo Clin Proc. 2011 Jan;86(1):63-9.Full text Abstract
12. Crum NF, Ballon-Landa G. Coccidioidomycosis in pregnancy: case report and review of the literature. Am J Med. 2006 Nov;119(11):993.e11-7. Abstract
13. Spinello IM, Johnson RH, Baqi S. Coccidioidomycosis in pregnancy: a review. Ann NY Acad Sci. 2007 Sep;1111:358-64. Abstract
14. Fisher MC, Koenig GL, White TJ, et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002 Jan-Feb;94(1):73-84. Abstract
15. Hector RF, Laniado-Laborin R. Coccidioidomycosis: a fungal disease of the Americas. PLoS Med. 2005 Jan;2(1):e2.Full text Abstract
16. Kirkland T, Fierer J. Coccidioidomycosis: a reemerging infectious disease. Emerg Infect Dis. 1996 Jul-Sep;2(3):192-9. Abstract
17. Anstead GM, Graybill JR. Coccidioidomycosis. Infect Dis Clin North Am. 2006 Sep;20(3):621-43. Abstract
18. Ampel MA. Coccidiodomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005 Oct 15;41(8):1174-8.Full text Abstract
19. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001 Nov 1;33(9):1536-44. Abstract
20. Glenn TJ, Blair JE, Adams RH. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol. 2005 Dec;43(8):705-10. Abstract
21. Muhsen IN, Galeano S, Niederwieser D, et al. Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) review. Lancet Haematol. 2023 Apr;10(4):e295-305. Abstract
22. Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006 Nov;119(11):964-9. Abstract
23. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Coccidioidomycosis. 2021 [internet publication].Full text
24. Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004 May;83(3):149-75. Abstract
25. Valdivia L, Nix D, Wright M, et al. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg Infect Dis. 2006 Jun;12(6):958-62.Full text Abstract
26. Hage CA, Carmona EM, Epelbaum O, et al. Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2019 Sep 1;200(5):535-50.Full text Abstract
27. Centers for Disease Control and Prevention. Fungal diseases: information for healthcare professionals about valley fever (coccidioidomycosis). Aug 2023 [internal publication].Full text
28. Crum NF. Coccidioidomycosis: a contemporary review. Infect Dis Ther. 2022 Apr;11(2):713-42.Full text Abstract
29. Smith DJ, Free RJ, Thompson Iii GR, et al. Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia for primary and urgent care providers. Clin Infect Dis. 2023 Oct 6:ciad619.Full text Abstract
30. Centers for Disease Control and Prevention. Fungal diseases: clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia. Nov 2023 [internet publication].Full text
31. Saubolle MA. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. 2007 Sep;1111:301-14. Abstract
32. Blair JE, Coakley B, Santelli AC, et al. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006 Nov;162(5):317-24. Abstract
33. Kaufman L, Sekhon AS, Moledina N, et al. Comparative evaluation of commercial Premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol. 1995 Mar;33(3):618-9.Full text Abstract
34. Nimer N, Camp T. Coccidioidomycosis. Pediatr Rev. 2015 Apr;36(4):181-2.
35. Malo J, Luraschi-Monjagatta C, Wolk DM, et al. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc. 2014 Feb;11(2):243-53.Full text Abstract
36. Garcia Garcia SC, Salas Alanis JC, Flores MG, et al. Coccidioidomycosis and the skin: a comprehensive review. An Bras Dermatol. 2015 Sep-Oct;90(5):610-9.Full text Abstract
37. Saubolle MA, Wojack BR, Wertheimer AM, et al. Multicenter clinical validation of a cartridge-based real-time PCR system for detection of coccidioides spp. in lower respiratory specimens. J Clin Microbiol. 2018 Jan 24;56(2):e01277-17.Full text Abstract
38. Donovan FM, Ramadan FA, Khan SA, et al. Comparison of a novel rapid lateral flow assay to enzyme immunoassay results for early diagnosis of coccidioidomycosis. Clin Infect Dis. 2021 Nov 2;73(9):e2746-53.Full text Abstract
39. Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am. 2003;17:41-57. Abstract
40. Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007 Jan;45(1):26-30.Full text Abstract
41. Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005 Nov 1;41(9):1217-23.Full text Abstract
42. Batra P, Batra RS. Thoracic coccidioidomycosis. Semin Roentgenol. 1996 Jan;31(1):28-44. Abstract
43. Zeppa MA, Laorr A, Greenspan A, et al. Skeletal coccidioidomycosis: imaging findings in 19 patients. Skeletal Radiol. 1996 May;25(4):337-43. Abstract
44. Wheat LJ, Kauffman CA. Histoplasmosis. Infect Dis Clin North Am. 2003 Mar;17(1):1-19, Abstract
45. Centers for Disease Control and Prevention. Fungal diseases: blastomycosis. Feb 2022 [internet publication].Full text
46. California Department of Public Health Infectious Diseases Branch. Guidance for managing select communicable diseases: coccidioidomycosis (valley fever). Dec 2018 [internet publication].Full text
47. Limper AH, Knox KS, Sarosi GA, et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011 Jan 1;183(1):96-128.Full text Abstract
48. Prabhu RM, Bonnell M, Currier BL, et al. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004 Oct 1;39(7):e74-7. Abstract
49. Caraway NP, Fanning CV, Stewart JM, et al. Coccidioidomycosis osteomyelitis masquerading as a bone tumor: a report of 2 cases. Acta Cytol. 2003 Sep-Oct;47(5):777-82. Abstract
50. Stevens DA, Rendon A, Gaona Flores V, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007 Sep;132(3):952-8. Abstract
51. Catanzaro A, Cloud GA, Stevens DA, et al. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis. 2007 Sep 1;45(5):562-8. Abstract
52. Rachwalski EJ, Wieczorkiewicz JT, Scheetz MH. Posaconazole: an oral triazole with an extended spectrum of activity. Ann Pharmacother. 2008 Oct;42(10):1429-38. Abstract
53. Kim MM, Vikram HR, Kusne S, et al. Treatment of refractory coccidioidomycosis with voriconazole or posaconazole. Clin Infect Dis. 2011 Dec;53(11):1060-6. Abstract
54. Blair JE. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Ann N Y Acad Sci. 2007 Sep;1111:411-21. Abstract
55. Blair JE. State-of-the-art treatment of coccidioidomycosis: skeletal infections. Ann N Y Acad Sci. 2007 Sep;1111:422-33. Abstract
56. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000 Nov 7;133(9):676-86. Abstract
Use of this content is subject to our disclaimer